Annual Report CSR & Financial Report

Overview

The report marks Daicel's 100th anniversary and presents FY2019/3 consolidated sales of ¥464.9 billion. It highlights the development of a drug delivery system and acquisitions of Lomapharm GmbH and Arbor Biosciences to expand healthcare, pharmaceutical and genomics businesses. The CSR section reports a 2% reduction in domestic-group CO2 emissions and zero-accident logistics status. It also records 26 occupational accidents across the stated domestic Group and partner-company boundaries.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2018-2019
Period: 1 April 2018 – 31 March 2019
Publication date: 1 September 2019
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Scope
Statement included
Metrics assured

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services